Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

NCT02132234 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Hypertension

Interventions

DRUG: Etanercept
DRUG: Adalimumab
DRUG: Certolizumab
DRUG: Infliximab

Sponsor

Jagiellonian University

Collaborators

[object Object]